Nitroxoline (8-hydroxy-5-nitroquinoline) is more a potent anti-cancer agent than clioquinol (5-chloro-7-iodo-8-quinoline).
暂无分享,去创建一个
W. Ding | Stuart E Lind | S. E. Lind | D. Benbrook | Wei-Qun Ding | Hongchao Jiang | Jori E Taggart | Xiaoxi Zhang | Doris M Benbrook | Xiaoxi Zhang | Hongchao Jiang | J. Taggart | S. Lind
[1] J. R. Lou,et al. Clioquinol independently targets NF-kappaB and lysosome pathways in human cancer cells. , 2010, Anticancer research.
[2] R. Mason,et al. Redox cycling of radical anion metabolites of toxic chemicals and drugs and the Marcus theory of electron transfer. , 1990, Environmental health perspectives.
[3] Yunfeng Zhou,et al. Clioquinol targets zinc to lysosomes in human cancer cells. , 2009, The Biochemical journal.
[4] Di Chen,et al. Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells , 2005, Breast Cancer Research.
[5] T. Meade. Subacute myelo-optic neuropathy and clioquinol. An epidemiological case-history for diagnosis. , 1975, British journal of preventive & social medicine.
[6] A. Mackinnon,et al. Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. , 2003, Archives of neurology.
[7] P. Wardman. Some reactions and properties of nitro radical-anions important in biology and medicine. , 1985, Environmental health perspectives.
[8] T. Tsubaki,et al. Neurological syndrome associated with clioquinol. , 1971, Lancet.
[9] Jun O. Liu,et al. Effect of nitroxoline on angiogenesis and growth of human bladder cancer. , 2010, Journal of the National Cancer Institute.
[10] L. Cahoon. The curious case of clioquinol , 2009, Nature Medicine.
[11] M. Selig,et al. Clioquinol-Zinc Chelate: A Candidate Causative Agent of Subacute Myelo-Optic Neuropathy , 1998, Molecular medicine.
[12] Bolin Liu,et al. Anticancer activity of the antibiotic clioquinol. , 2005, Cancer research.
[13] B. Halliwell,et al. Free radicals in biology and medicine , 1985 .
[14] F. Sarkar,et al. Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts. , 2007, Cancer research.
[15] K. Blennow,et al. Treatment of Alzheimer’s Disease with Clioquinol , 2001, Dementia and Geriatric Cognitive Disorders.
[16] L. Kay,et al. Clioquinol inhibits the proteasome and displays preclinical activity in leukemia and myeloma , 2009, Leukemia.
[17] D. Andersson,et al. Clioquinol and pyrithione activate TRPA1 by increasing intracellular Zn2+ , 2009, Proceedings of the National Academy of Sciences.
[18] Jie Zheng,et al. N-Acetylcysteine interacts with copper to generate hydrogen peroxide and selectively induce cancer cell death. , 2010, Cancer letters.
[19] H. Koornhof,et al. Antibacterial activity of nitroxoline and sulphamethizole alone and in combination in urinary tract infections. , 1978, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[20] P. Crouch,et al. Clioquinol Promotes Cancer Cell Toxicity through Tumor Necrosis Factor α Release from Macrophages , 2008, Journal of Pharmacology and Experimental Therapeutics.